Next-generation immune cell therapies for lung cancer: advances in CAR-T, NK, and TIL strategies

Lung cancer remains the leading cause of cancer-related mortality worldwide, and current therapies offer limited survival benefit for patients with advanced disease. While immune checkpoint inhibitors and targeted therapies have improved outcomes in some populations, most patients either fail to res...

Descripció completa

Dades bibliogràfiques

Autors principals:	Anoud Khan, Amina Mujahid, Aryan Tareen, Ahrar Amin, Saqib Raza Khan, Danial Khan Hadi, Afsheen Raza
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2026-03-01
Col·lecció:	Frontiers in Medicine
Matèries:	chimeric antigen receptor natural killer cells chimeric antigen receptor T cells lung cancer next generation immune cell therapies tumor infiltrating lymphocytes
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fmed.2026.1787086/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!